In this episode of the Drug Solutions Podcast, Feliza Mirasol, Pharmaceutical Technology’s science editor, discusses technologies enabling biologics and emerging therapies manufacturing and development with Barry Holtz, PhD, chief scientific officer of Phylloceuticals, and Professor Yaakov Nahmias, founder and chief scientific officer, Tissue Dynamics and founder and president, Future Meat Technologies.
Kathleen Brunner from Acumen Analytics discusses how important it is to keep the end in mind at the beginning with any process by involving artificial intelligence. This strategy eliminates informational roadblocks and improves pharmaceutical production.
Kathleen Brunner from Acumen Analytics discusses how important a centralized location for data is, especially in the life science field.
Dr. Jeanne Novak discusses how the science of PMP was demonstrated to the FDA.
Dr. Jeanne Novak speaks on the first PMP vaccine developed and why it was so important in the FDA approval process.
Special guest Jeanne Novak, Ph.D. joined Dr. Barry Holtz on Phylloside chats.
Dr. Barry Holtz discusses how COVID-19 revealed food and pharma insecurity around the globe.
Dr. Barry Holtz discusses how COVID-19 revealed food|pharma insecurity around the globe.
From a career spent designing facilities and installing huge stainless steel bioreactors, listen as Bill Brydges describes the quantum leap made by using plants as bioreactors.